Representatives and Notices. Each Party nominates as its representative for this Agreement the person set out on the first page of this Agreement under ‘Contact for Notices’ (“Representative”). Any communication under this Agreement must be in writing and sent to the recipient Party’s Representative. In the event that a Party (Provider) provides the other Party (User) with Material: the Material will be solely owned by the Provider; the User must store, handle and use the Material in compliance with all applicable legislation, regulations, codes and guidelines; the User must use the Material solely for the purpose of the Project and for no other purpose; the User must not use the Material in human subjects; the User must not, without the prior written consent of the Subject: transfer, distribute or disclose the Material to any third party external to the User; use the Material for commercial, diagnostic or therapeutic purposes; acknowledges that the Material are: experimental in nature and may have defects, deficiencies and hazardous properties; provided by the Provider without warranty, express or implied, and to the full extent permitted by law, all warranties related to the Material are excluded; and stored, handled and used at the Users’ sole risk. To the extent that the Provider has any legal rights in the Material, the Provider grants to the User a non-exclusive royalty free, transferable, worldwide licence to use, adapt and modify the Material for the purpose of performing the Project and carrying out its obligations under this Agreement and in accordance with the relevant Clinical Subject consent. Following termination of a Project and upon receipt of a written request by the Provider, the User must promptly return to the Provider (at the Provider’s expense) or destroy any unused Materials.
Appears in 13 contracts
Samples: Research Collaboration Agreement, Research Collaboration Agreement, Research Collaboration Agreement
